Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PAAD | rs138893084 | chr11:125582641 | T/C | 0.000112 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
| PAAD | rs138935728 | chr16:68745275 | AAG/A | 6.39E-5 | 175 | 16.15 | 14.18 | 5.97 | KM Plot |
| PAAD | rs138967970 | chr7:6181870 | C/CG | 0 | 176 | 15.37 | 15.77 | 1.03 | KM Plot |
| PAAD | rs139246494 | chr19:49359147 | T/C | 1.47E-12 | 174 | 16.28 | 13.13 | 1.37 | KM Plot |
| PAAD | rs139392063 | chr5:60134638 | G/A | 8.43E-5 | 174 | 15.3 | 16.17 | 4.68 | KM Plot |
| PAAD | rs139410190 | chr17:27391617 | A/AT | 1.38E-5 | 170 | 14.35 | 18.17 | 5.03 | KM Plot |
| PAAD | rs139455718 | chr17:18277417 | AAGG/A | 1.82E-5 | 175 | 15.57 | 15.27 | 3.67 | KM Plot |
| PAAD | rs139538017 | chr19:23163897 | CTGA/C | 8.57E-13 | 178 | 15.55 | 15.4 | 1.37 | KM Plot |
| PAAD | rs139640039 | chr17:26984636 | G/A | 1.68E-5 | 175 | 15.43 | 16.03 | 3.67 | KM Plot |
| PAAD | rs139708801 | chr1:114848759 | C/T | 0 | 174 | 0.4 | 15.27 | 15.57 | KM Plot |
| PAAD | rs139715349 | chr19:49346538 | C/T | 1.22E-12 | 174 | 16.17 | 12.87 | 1.37 | KM Plot |
| PAAD | rs139727359 | chr3:14234137 | T/C | 2.42E-6 | 174 | 15.48 | 15.57 | 3.43 | KM Plot |
| PAAD | rs139828754 | chr12:53275537 | CA/C | 0 | 176 | 15.62 | 13.47 | 1.03 | KM Plot |
| PAAD | rs139829439 | chr10:102947024 | GT/G | 1.56E-7 | 172 | 15.82 | 14.03 | 3.17 | KM Plot |
| PAAD | rs139846687 | chr11:125570252 | TGA/T | 4.48E-5 | 177 | 16.05 | 11.6 | 4.1 | KM Plot |